EGAPP logo

EGAPP logo

Evaluation of Genomic Applications in Practice and Prevention
Working Group

Meetings & Conferences


September 30 – October 1, 2008
Talaris Conference Center, Seattle, WA

Agenda

This meeting will be in CLOSED session on Tuesday, September 30th.

Please note that the OPEN session for this meeting will be on
Wednesday, October 1st from 8:00 am to 2:00pm

Tuesday, September 30
Time
Activity
Speaker

8:30 – 9:30

EGAPP Working Group Subcommittee Breakout Sessions
  • Methods
  • Topics
  • Products

Steve Teutsch
Joan Scott
Celia Kaye

9:30 – 9:45

Welcome and Opening Statement

Al Berg, Chair

9:45 – 10:15

Recap on EGAPP Working Group Retreat held September 29, 2008.

Al Berg

10:15 – 10:30

Break

 

10:30 – 11:00

EGAPP Staff updates

Dave Dotson

11:00 – 12:00

Status Report: Use of Genomic Profiling to Assess Risk for Cardiovascular Disease and Identify Individualized Prevention Strategies

Glenn Palomaki &
Cecile Janssens

12:00 - 1:30

12:30 - 1:00

1:00 - 1:30

Working Lunch & Presentations

  • Institute of Medicine (IOM) Roundtable on Translating  Genomic-based Research
  • Secretary’s Advisory Committee on Genetics, Health and Society (SACGHS)

 

Wylie Burke, Chair, IOM

Steve Teutsch, Chair, SACGHS

1:30 – 3:00

Breakout Session 1:  Use of Genomic Profiling to Assess Risk for Cardiovascular Disease and Identify Individualized Prevention Strategies

Breakout Session 2:  Methodology Development and Updating of Evidence Reports and Recommendations

Work Group Members & Consultants


Work Group Members & Consultants

3:00 – 3:15

Break

 

3:15 – 4:00

Breakout Session 1 Report and Discussion

Work Group Members & Consultants

4:00 – 4:45 Breakout Session 2 Report and Discussion Work Group Members & Consultants
4:45 – 5:00 Wrap-up and Adjourn Closed Session Al Berg

 

Wednesday, October 1
Time
Activity
Speaker

7:30 – 8:00

Breakfast for Working Group in Meeting Room

 

8:00 – 8:30

Overview of Day 1, brief staff updates and outstanding questions

Al Berg & Staff

8:30 – 9:00

Topics Subcommittee Report

Joan Scott

9:00 – 9:30

Planning for Future Topics Discussion

Working Group  Members and Consultants

9:30 – 10:00 Status Review:  Multigene testing to assess risk of Type II Diabetes  Working Group  Members and Consultants

10:00 – 10:15

10:15 – 10:30

Public Comment

EGAPP Stakeholders Group Meeting Report

 

Debra Leonard, ESG Chair

10:30 – 10:45

Break and Checkout

 
10:45 – 11:15 Methods Subcommittee Report Steve Teutsch
11:15 – 11:45 Products Subcommittee Report Celia Kaye
11:45 – 12:00 Pick Up Lunch  

12:00 – 1:00

Lunch

 

1:00 – 2:00

Wrap-up and Action Items

Al Berg

2:00

Adjourn